Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Shapiro

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMC Cancer|October 18, 2005
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapyL Lim, P Gibbs, D Yip, et al.
Internal Medicine Journal|April 20, 2005
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignanciesL Lim, P Gibbs, D Yip, et al.
Australian and New Zealand Journal of Medicine|February 1, 1997
Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancerJ D Shapiro, M J Millward, D Rischin, et al.
Cancer|November 7, 1998
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancerJ D Shapiro, M L Rothenberg, G A Sarosy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparisonG C Toner, J D Shapiro, C R Laidlaw, et al.
Cancer Treatment and Research Communications|June 17, 2024
Early onset metastatic colorectal cancer in AustraliaA Jalali, S Smith, G Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinomaJ D Shapiro, N Harold, C Takimoto, et al.
Current Problems in Cancer|September 27, 2021
Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancerA Jalali, G Gard, S Banks, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patientsR R Thomas, W Dahut, N Harold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17M M Vickers, C S Karapetis, D Tu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Cancer|October 18, 2005
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapyL Lim, P Gibbs, D Yip, et al.
Internal Medicine Journal|April 20, 2005
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignanciesL Lim, P Gibbs, D Yip, et al.
Australian and New Zealand Journal of Medicine|February 1, 1997
Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancerJ D Shapiro, M J Millward, D Rischin, et al.
Cancer|November 7, 1998
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancerJ D Shapiro, M L Rothenberg, G A Sarosy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparisonG C Toner, J D Shapiro, C R Laidlaw, et al.
Cancer Treatment and Research Communications|June 17, 2024
Early onset metastatic colorectal cancer in AustraliaA Jalali, S Smith, G Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinomaJ D Shapiro, N Harold, C Takimoto, et al.
Current Problems in Cancer|September 27, 2021
Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancerA Jalali, G Gard, S Banks, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patientsR R Thomas, W Dahut, N Harold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17M M Vickers, C S Karapetis, D Tu, et al.
Pageof 3